Cleared Traditional

K840443 - RETROGRADE INFUSION SET 3ML & 6ML-

K840443 is the FDA 510(k) clearance for RETROGRADE INFUSION SET 3ML & 6ML- by Tico Medical Instruments, Inc.. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 76-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1984
Decision
76d
Days
Class 2
Risk

K840443 is an FDA 510(k) clearance for the RETROGRADE INFUSION SET 3ML & 6ML-. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Tico Medical Instruments, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 17, 1984 after a review of 76 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tico Medical Instruments, Inc. devices

Submission Details

510(k) Number K840443 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 1984
Decision Date April 17, 1984
Days to Decision 76 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 129d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 471
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K840443.
FLUID ADMINISTRATION LINE W/SPIKE 14-923
K842858 · Norton Performance Plastics Corp. · Sep 1984
T-TYPE IV EXTENSION SET
K843249 · Strato Medical Corp. · Sep 1984
SYRINGE ADDITIVE IV ADMIN. SETS
K841361 · Quest Medical, Inc. · May 1984
HARVARD ANTI-REFLUX Y-SET
K840760 · C.R. Bard, Inc. · Apr 1984
QUIK LOK
K840878 · Abbott Laboratories · Mar 1984
LOPEZ LOCK
K840273 · Icu Medical, Inc. · Mar 1984